UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 106

Sortiert nach

Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram

Cell communication and signaling, 2020-03, Vol.18 (1), p.36-14, Article 36

2020

Volltextzugriff (PDF)

Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment

Nature communications, 2023-09, Vol.14 (1), p.5727-5727, Article 5727

2023

Volltextzugriff (PDF)

Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram

Frontiers in oncology, 2022-07, Vol.12, p.913736-913736

2022

Volltextzugriff (PDF)

Phenotype of p53 wild-type epitope-specific T cells in the circulation of patients with head and neck cancer

Scientific reports, 2018-07, Vol.8 (1), p.10716-9, Article 10716

2018

Volltextzugriff (PDF)

Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts

Cells (Basel, Switzerland), 2021-02, Vol.10 (3), p.517

2021

Volltextzugriff (PDF)

A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients

Cancer Immunology, Immunotherapy, 2012-03, Vol.61 (3), p.373-384

2012

Volltextzugriff (PDF)

Role of Antigen-Processing Machinery in the In Vitro Resistance of Squamous Cell Carcinoma of the Head and Neck Cells to Recognition by CTL

Journal of Immunology, 2006-03, Vol.176 (6), p.3402-3409

2006

Volltextzugriff (PDF)

Correction to: Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram

Cell communication and signaling, 2020-04, Vol.18 (1), p.53-53, Article 53

2020

Volltextzugriff (PDF)

The p53 Saga: Early Steps in the Development of Tumor Immunotherapy

The Journal of immunology (1950), 2020-05, Vol.204 (9), p.2321-2328

2020

Volltextzugriff (PDF)

Targeting cancer stem cells with ALDH1A1-based immunotherapy

Oncoimmunology, 2012-05, Vol.1 (3), p.385-387

DeLeo, Albert B.

2012

Volltextzugriff (PDF)

Targeting Radiation-Resistant Prostate Cancer Stem Cells by B7-H3 CAR T Cells

Molecular cancer therapeutics, 2021-03, Vol.20 (3), p.577-588

2021

Volltextzugriff (PDF)

Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation

Cancer letters, 2021-05, Vol.505, p.37-48

2021

Volltextzugriff (PDF)

Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells

Clinical cancer research, 2011-10, Vol.17 (19), p.6174-6184

2011

Volltextzugriff (PDF)

Induction of autophagy-dependent apoptosis in cancer cells through activation of ER stress: an uncovered anti-cancer mechanism by anti-alcoholism drug disulfiram

American journal of cancer research, 2019-01, Vol.9 (6), p.1266-1281

2019

Volltextzugriff (PDF)

Blocking the formation of radiation-induced breast cancer stem cells

Oncotarget, 2014-06, Vol.5 (11), p.3743-3755

2014

Volltextzugriff (PDF)

Identification of Human Aldehyde Dehydrogenase 1 Family Member A1 as a Novel CD8+ T-Cell-Defined Tumor Antigen in Squamous Cell Carcinoma of the Head and Neck

Cancer research (Chicago, Ill.), 2007-11, Vol.67 (21), p.10538-10545

2007

Volltextzugriff (PDF)

Targeting cancer stem cells with p53 modulators

Oncotarget, 2016-07, Vol.7 (29), p.45079-45093

2016

Volltextzugriff (PDF)

17β hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma

Gynecologic oncology, 2012-12, Vol.127 (3), p.587-594

2012

Volltextzugriff (PDF)

PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions

Oral oncology, 2013-02, Vol.49 (2), p.144-151

2013

Volltextzugriff (PDF)

Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice

Cancer immunology research, 2016-05, Vol.4 (5), p.441-451

2016

Volltextzugriff (PDF)

Immune responses to p53 in patients with cancer:Enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites

Cancer Immunology, Immunotherapy, 2005-11, Vol.54 (11), p.1072-1081

2005

Volltextzugriff (PDF)

Development of multi-epitope vaccines targeting wild-type sequence p53 peptides

Expert review of vaccines, 2008-09, Vol.7 (7), p.1031-1040

2008

Volltextzugriff (PDF)

Identification of Hydroxysteroid (17β) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas

Cancer Immunology, Immunotherapy, 2011-07, Vol.60 (7), p.919-929

2011

Volltextzugriff (PDF)

CD8+ T cell recognition of polymorphic wild-type sequence p53(65-73) peptides in squamous cell carcinoma of the head and neck

Cancer immunology, immunotherapy, 2010-10, Vol.59 (10), p.1561-1568

2010

Volltextzugriff (PDF)

p53110-124-specific human CD4+ T-helper cells enhance in vitro generation and antitumor function of tumor-reactive CD8+ T cells

Cancer research (Chicago, Ill.), 2003-07, Vol.63 (13), p.3675-3681

2003

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(102)

Publikationsform

Artikel
(105)
Buchkapitel
(1)

Sprache

Englisch
(106)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(72)
Life Sciences & Biomedicine
(66)
Animals
(45)
Mice
(39)
Humans
(38)
Oncology
(34)
Immunology
(27)
Biological And Medical Sciences
(26)
Tumors
(26)
Medical Sciences
(23)
Female
(22)
Tumor Suppressor Protein P53 - Immunology
(17)
Sarcoma, Experimental - Immunology
(15)
T-Lymphocytes, Cytotoxic - Immunology
(14)
Antigens, Neoplasm - Immunology
(13)
Dendritic Cells - Immunology
(13)
Cd8-Positive T-Lymphocytes - Immunology
(12)
Cell Line
(12)
Cell Line, Tumor
(12)
Cells, Cultured
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram

Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment

Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram

Phenotype of p53 wild-type epitope-specific T cells in the circulation of patients with head and neck cancer

Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts

A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients

Role of Antigen-Processing Machinery in the In Vitro Resistance of Squamous Cell Carcinoma of the Head and Neck Cells to Recognition by CTL

Correction to: Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram

The p53 Saga: Early Steps in the Development of Tumor Immunotherapy

Targeting cancer stem cells with ALDH1A1-based immunotherapy

Targeting Radiation-Resistant Prostate Cancer Stem Cells by B7-H3 CAR T Cells

Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation

Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells

Induction of autophagy-dependent apoptosis in cancer cells through activation of ER stress: an uncovered anti-cancer mechanism by anti-alcoholism drug disulfiram

Blocking the formation of radiation-induced breast cancer stem cells

Identification of Human Aldehyde Dehydrogenase 1 Family Member A1 as a Novel CD8+ T-Cell-Defined Tumor Antigen in Squamous Cell Carcinoma of the Head and Neck

Targeting cancer stem cells with p53 modulators

17β hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma

PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions

Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice

Immune responses to p53 in patients with cancer:Enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites

Development of multi-epitope vaccines targeting wild-type sequence p53 peptides

Identification of Hydroxysteroid (17β) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas

CD8+ T cell recognition of polymorphic wild-type sequence p53(65-73) peptides in squamous cell carcinoma of the head and neck

p53110-124-specific human CD4+ T-helper cells enhance in vitro generation and antitumor function of tumor-reactive CD8+ T cells

Suchergebnisse filtern